THE FACT ABOUT ABBV-744 IN COMBINATION WITH IMMUNOTHERAPY THAT NO ONE IS SUGGESTING

In Phase A, individuals will receive various doses and schedules of oral ABBV-744 pill to identify Secure dosing program. More members will likely be enrolled in the identified monotherapy dosign routine. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be given as "include-on" therapy. In Phase C, individuals will